The Leadership Team at Skyhawk Therapeutics is responsible for guiding the company's strategic vision and operational direction. Comprising executives with expertise in market development, legal affairs, chemistry, and overall management, this team fosters innovation, drives drug development initiatives, and ensures alignment across all functions to enhance the efficacy of small molecule therapies for RNA splicing disorders.
View all